Endometriosis - Recent Advances, New Perspectives and Treatments

Giovana Gonçalves
2021 · doi:10.5772/intechopen.95742 · W4200036200
book OA: gold CC0
🔓 Open OA copy Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-06 ⓘ

This book reviews recent advances in endometriosis, covering molecular diagnostics, imaging for early detection, and new fertility-sparing treatments to reduce economic costs and improve patient outcomes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-06 · read from full text ⓘ

This edited volume/book chapter overview describes endometriosis as a common, serious condition with substantial economic costs, largely from lost work productivity, and argues for earlier diagnosis and more effective management. It covers recent advances including approaches for molecular diagnostics and imaging methods aimed at early detection, as well as new, less-invasive treatment options intended to preserve fertility. The main limitation is that, as a comprehensive overview, it does not present a single original study with a defined study population or outcomes. This paper is centrally about endometriosis — it provides a broad overview of recent advances, diagnostic perspectives, and less-invasive treatments.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis is a common and serious disease that is estimated to cost the world economy $9.7 billion a year. Most of these costs come from lost productivity at work. As such, it is important to help women receive earlier diagnosis and more effective treatment. This book presents a comprehensive overview of endometriosis, including information on molecular diagnostics and imaging methods for early detection as well as new, less-invasive treatments that preserve women’s fertility.
Full text 904 characters · extracted from oa-html · click to expand
Endometriosis Recent Advances, New Perspectives and Treatments Contributor(s) Gonçalves, Giovana Ap. (editor) Language EnglishAbstract Endometriosis is a common and serious disease that is estimated to cost the world economy $9.7 billion a year. Most of these costs come from lost productivity at work. As such, it is important to help women receive earlier diagnosis and more effective treatment. This book presents a comprehensive overview of endometriosis, including information on molecular diagnostics and imaging methods for early detection as well as new, less-invasive treatments that preserve women’s fertility. Keywords Gynaecology & obstetricsWebshop link https://www.intechopen.com/boo ...ISBN 9781839699214, 9781839699207, 9781839699221Publisher IntechOpenPublisher website https://www.intechopen.com/Publication date and place 2022Imprint IntechOpenClassification Gynaecology and obstetrics

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK